More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$40.21B
EPS
0.16
P/E ratio
19.4
Price to sales
2.75
Dividend yield
1.395%
Beta
0.152968
Previous close
$9.17
Today's open
$9.31
Day's range
$9.19 - $9.34
52 week range
$8.38 - $11.28
show more
CEO
Brian McNamara
Employees
24000
Headquarters
Weybridge, Surrey
Exchange
New York Stock Exchange
Shares outstanding
4.40B
Issue type
American Depository Receipt
Healthcare
Pharmaceuticals
ASAIY vs. HLN: Which Stock Is the Better Value Option?
Investors with an interest in Consumer Products - Discretionary stocks have likely encountered both Sendas Distribuidora S.A. Sponsored ADR (ASAIY) and Haleon PLC Sponsored ADR (HLN).
Zacks Investment Research • 16 hours ago

Haleon: If Staples Hold Up, The Stock Should Outperform
Haleon has underperformed since its 2022 spin from GSK, delivering just over 6% annualized returns, including dividends. HLN's valuation has compressed, with its forward EV/EBITDA multiple now at an all-time low, reflecting diminished growth expectations. But at the lower price, the disappointment looks priced in; as long as Haleon can avoid a packaged food-style margin collapse, risk/reward is heavily in shareholders' favor.
Seeking Alpha • Nov 12, 2026

Buy 18 Ideal 'Safer' November Dividend Dogs Of 10-Year Tenured 81
I curated 81 top Ten-Year tenured dividend dogs using a yield-based dogcatcher analysis, focusing on high-yield, long-duration dividend payers. Chimera Investment (CIM), Mach Natural Resources (MNR), and Opera Ltd (OPRA) are projected for the highest net gains through November 2027, with CIM leading at 117.47%. 18 of 36 'Safer' tenured dividend dogs meet the ideal of annual dividends from $1K invested exceeding their share price, signaling attractive entry points.
Seeking Alpha • Nov 11, 2026

Sensodyne maker Haleon cuts revenue growth forecast on weak flu season, China disruption
British consumer health company Haleon cut its annual organic revenue growth forecast on Thursday after weak demand for cold medicines and a regulatory setback in China weighed on sales.
Reuters • Oct 29, 2026

Haleon CEO warns staff of 'difficult choices' ahead after sales miss, memo says
Haleon CEO Brian McNamara warned staff on Thursday that the British maker of Sensodyne toothpaste faced "difficult choices" in the months ahead, according to a memo seen by Reuters, after
Reuters • Oct 29, 2026

Haleon Shares Dive After Advil Maker Cuts Guidance
Performance was held back by weaker sales in cough, cold and flu products, particularly with lower orders in North America.
WSJ • Oct 29, 2026

Haleon plc (HLN) Q3 2026 Sales/Trading Call Transcript
Haleon plc (HLN) Q3 2026 Sales/Trading Call Transcript
Seeking Alpha • Oct 29, 2026

Consumer Healthcare Giant Haleon Plunges to 52-Week Low
Haleon Plc (NYSE:HLN) shares dropped to a 52-week low on Thursday after the consumer health company cut its full-year guidance.
Benzinga • Oct 29, 2026

What Haleon (HLN) Said on Its Q3 Earnings Call
Haleon NYSE: HLN said its third-quarter performance fell below expectations, citing weaker-than-anticipated North American growth, a softer cough, cold and flu season, a Chinese classification issue affecting Centrum, and continued challenging consumer conditions in Europe.
MarketBeat • Oct 29, 2026

ASAIY or HLN: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Consumer Products - Discretionary sector might want to consider either Sendas Distribuidora S.A. Sponsored ADR (ASAIY) or Haleon PLC Sponsored ADR (HLN).
Zacks Investment Research • Oct 29, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Haleon plc American Depositary Shares (Each representing two) commission-free¹. Build wealth for the long term using automated trading and transfers.